CLUSTER filed Aug 27, 2026 at 16:12 ET
Four Medpace insiders, including the CEO, CFO, and two directors, sold a total of $10.0M in shares over a one-week window. The CEO's sales ($4.1M) and the CFO's sale ($2.1M) are notable for their size and seniority, but the total represents only ~0.06% of the company's $17.1B market cap, falling below the 0.1% materiality threshold. The sales are likely driven by routine portfolio diversification and tax planning, not a bearish signal on fundamentals, especially given the weak predictive power of insider sales clusters per the academic literature.